Scharte M, Meyer J, Van Aken H, Bone H G
Klinik und Poliklinik für Anästhesiologie und operative Intensivmedizin, Westfälische Wilhelms-Universität Münster, Münster, Germany.
Crit Care Med. 2001 Sep;29(9):1756-60. doi: 10.1097/00003246-200109000-00017.
Hypotension, vasodilation, and vasoplegia are characteristic signs of septic shock. The vasoconstrictive response to catecholamines typically is reduced. A decreased vasopressive effect of catecholamines can be observed in the late phase of hemorrhagic shock. Interestingly, an unaltered vasopressive response to vasopressin can be demonstrated in hemorrhagic shock. In this study, we investigated the vasoconstrictive response to an agonist of the vasopressin receptor, terlipressin, in healthy sheep as well as in ovine hyperdynamic endotoxemia.
Prospective controlled trial.
University research laboratory.
Six female adult sheep.
Healthy sheep, instrumented for chronic study, received terlipressin (15 microg/kg) as a bolus; 30 mins later, norepinephrine was continuously given for 30 mins. Three hours later, a continuous infusion of endotoxin (Salmonella typhosa, 10 ng x kg(-1) x min(-1)) was started in the same sheep and given for the next 23 hrs. After 20 hrs of endotoxemia, terlipressin and norepinephrine were given as described previously.
Hemodynamic parameters were measured before and 30 mins after application of terlipressin and after 30 mins of continuous infusion of norepinephrine. Terlipressin significantly increased systemic vascular resistance index in healthy and endotoxemic sheep (p <.05). The increase was higher in endotoxemic compared with healthy animals (p <.05). Only during endotoxemia, terlipressin increased pulmonary vascular resistance index. This was accompanied by a significant decrease in cardiac index, whereas mean pulmonary arterial pressure did not change after application of terlipressin. Additional treatment with norepinephrine did not further increase systemic vascular resistance index or pulmonary vascular resistance index.
Terlipressin reversed the hemodynamic changes in ovine endotoxemia. However, its pulmonary vasopressive effect might limit its therapeutic use in septic shock.
低血压、血管扩张和血管麻痹是感染性休克的典型体征。对儿茶酚胺的血管收缩反应通常会降低。在失血性休克后期可观察到儿茶酚胺的血管升压作用减弱。有趣的是,在失血性休克中对血管加压素的血管升压反应未改变。在本研究中,我们调查了血管加压素受体激动剂特利加压素对健康绵羊以及绵羊高动力性内毒素血症的血管收缩反应。
前瞻性对照试验。
大学研究实验室。
6只成年雌性绵羊。
为进行慢性研究而安装仪器的健康绵羊接受一次特利加压素推注(15微克/千克);30分钟后,持续给予去甲肾上腺素30分钟。3小时后,对同一只绵羊开始持续输注内毒素(伤寒沙门氏菌,10纳克×千克⁻¹×分钟⁻¹),并在接下来的23小时内持续给药。内毒素血症20小时后,按先前所述给予特利加压素和去甲肾上腺素。
在应用特利加压素前、应用后30分钟以及持续输注去甲肾上腺素30分钟后测量血流动力学参数。特利加压素显著增加了健康和内毒素血症绵羊的全身血管阻力指数(p<.05)。与健康动物相比,内毒素血症动物的增加幅度更高(p<.05)。仅在内毒素血症期间,特利加压素增加了肺血管阻力指数。这伴随着心脏指数显著下降,而应用特利加压素后平均肺动脉压未改变。额外给予去甲肾上腺素并未进一步增加全身血管阻力指数或肺血管阻力指数。
特利加压素逆转了绵羊内毒素血症的血流动力学变化。然而,其肺血管升压作用可能会限制其在感染性休克中的治疗应用。